Related Experiment Video
Updated: Dec 12, 2025
06:40
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
1.7K
A clinically validated human capillary blood transcriptome test for global systems biology studies.
Ryan Toma1, Nathan Duval1, Benjamin Pelle2
1Viome, Inc., Bellevue, WA/Los Alamos, NM/New York, NY/San Diego, CA, USA.
Biotechniques
|August 11, 2020
Summary
A new whole blood transcriptome test uses minimal blood for chronic disease research. This accessible method enables safe global transport and automated analysis for large-scale population studies.
Area of Science:
- Systems biology
- Molecular diagnostics
- Genomics
Background:
- Chronic diseases, including cancer, require global approaches for prevention and treatment.
- Systems biology offers a framework for understanding complex diseases.
Purpose of the Study:
- To develop a whole blood transcriptome test for global application in chronic disease research.
- To create an accessible and scalable method for molecular diagnostics.
Main Methods:
- A whole blood transcriptome test utilizing 50 μl of capillary blood.
- Sample preservation at ambient temperature for up to 4 weeks.
- Automated laboratory and bioinformatic procedures in a clinical setting.
Main Results:
- The test is suitable for global use due to sample stability and pathogen inactivation.
- Automated processes minimize batch effects and ensure unbiased datasets.
- The test demonstrates clinical performance and accessibility to diverse populations.
Conclusions:
- This accessible whole blood transcriptome test can reveal disease molecular mechanisms.
- It enables longitudinal, population-scale studies for chronic disease research.
- The method supports global health initiatives by providing scalable molecular diagnostics.
